Key result
Anticoagulation for a single subsegmental pulmonary embolus remains highly debated among clinical experts.
Why the study?
Does anticoagulation therapy improve outcomes in a patient with a single subsegmental pulmonary embolus?
Does anticoagulation therapy improve outcomes in a patient with a single subsegmental pulmonary embolus?
This interactive feature discusses the clinical dilemma of whether to anticoagulate a patient with a single subsegmental pulmonary embolism.
Individualize anticoagulation for isolated subsegmental PE; leaves open whether benefits outweigh harms without randomized data.
This interactive feature about a patient with a single subsegmental pulmonary embolus offers a case vignette accompanied by essays that either support or discourage the use of anticoagulation therapy for this type of embolism.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2019) studied this question. Anticoagulation therapy for a single subsegmental pulmonary embolus is a subject of clinical debate, with expert perspectives both supporting and discouraging its use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: